Fabtech Technologies Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Fabtech Technologies Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, equals 28% of its market value (net cash). Higher than 98% of Healthcare companies in India.
- Debt Due Cover Ratio: Debt due within a year is covered 0.0 times by its yearly operating cash. Lower than 88% of Healthcare companies in India.
- Profit Cash Ratio: Over the last 3 years, every ₹100 of reported profit came with ₹22 of operating cash. Lower than 87% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹22Over the last 3 years, every ₹100 of reported profit came with ₹22 of operating cash.
Lower than 87% of Healthcare companies in India.
Self-Funding Ratio
0.8×Over the last 3 years its own operating cash paid for 81% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 70% of Healthcare companies in India.
Cash Locked Ratio
₹29For every ₹100 of sales, ₹29 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹32 tied up three years earlier.
More money tied up than 61% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹8Sales grew 111% in 3 years; of every extra ₹100 of sales, ₹8 became extra profit.
Lower than 74% of Healthcare companies in India.
Asset Productivity Ratio
+111% / +223%In 3 years sales changed by +111% while total assets changed by +223%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.0×Debt due within a year is covered 0.0 times by its yearly operating cash.
Lower than 88% of Healthcare companies in India.
Cash Cushion Ratio
+28%Cash, after subtracting all debt, equals 28% of its market value (net cash).
Higher than 98% of Healthcare companies in India.
Tangible Assets Ratio
97%Of every ₹100 the company owns, ₹97 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 53% of Healthcare companies in India.
Tangible Net Worth Ratio
94%Of every ₹100 of net worth, ₹94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 53% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Fabtech Technologies Limited owes ₹0.39 for every ₹1 it owns. Net profit fell 17% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
10.0Investors pay ₹10.0 for every ₹1 of Fabtech Technologies Limited's yearly profit, lower than 97% of Healthcare companies in India.
P/B ratio
1.30The share price is 1.30 times Fabtech Technologies Limited's book value per share, lower than 95% of Healthcare companies in India.
Market cap
₹546 CrThe total market value of all of Fabtech Technologies Limited's shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹420 CrWhat Fabtech Technologies Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹94.43Net worth divided by the number of shares. The share price of ₹122.79 is 1.3 times this, which is the P/B above.
Return on equity (ROE)
11.3%Fabtech Technologies Limited earned 11.3% on its shareholders' money over the last year, lower than 59% of Healthcare companies in India.
Owes vs Owns
0.39×Fabtech Technologies Limited owes ₹0.39 for every ₹1 it owns (low), higher than 57% of Healthcare companies in India.
Dividend yield
0.45%Fabtech Technologies Limited pays 0.45% of its share price as dividends a year, higher than 56% of dividend-paying Healthcare companies in India.
Revenue growth
+27%Revenue rose 27% in the year to Mar 2026, and grew 28% a year on average over 3 years.
Profit growth
-17%Net profit fell 17% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Profit margin
9.4%Fabtech Technologies Limited keeps ₹9 of every ₹100 of revenue as net profit.
Cash quality
0.0×Cash from Fabtech Technologies Limited's business was 0.0× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
6.8×Fabtech Technologies Limited's operating profit covered its interest costs 6.8 times in the year to Mar 2026.
Cash vs debt
Net cashFabtech Technologies Limited held ₹154 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is Fabtech Technologies Limited's P/E ratio?
Investors pay ₹10.0 for every ₹1 of Fabtech Technologies Limited's yearly profit, lower than 97% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Fabtech Technologies Limited: ₹546 Cr ÷ ₹420 Cr (31 Mar 2026) = 1.3.
What is Fabtech Technologies Limited's return on equity?
Fabtech Technologies Limited earned 11.3% on its shareholders' money over the last year, lower than 59% of Healthcare companies in India.
How much does Fabtech Technologies Limited owe compared with what it owns?
Fabtech Technologies Limited owes ₹0.39 for every ₹1 it owns (low), higher than 57% of Healthcare companies in India.
Does Fabtech Technologies Limited pay a dividend?
Yes. Fabtech Technologies Limited pays 0.45% of its share price as dividends a year, higher than 56% of dividend-paying Healthcare companies in India.
Is Fabtech Technologies Limited's revenue growing?
Revenue rose 27% in the year to Mar 2026, and grew 28% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.